BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15946342)

  • 1. Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus.
    Iannetti P; Spalice A; Parisi P
    Epilepsia; 2005 Jun; 46(6):967-9. PubMed ID: 15946342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
    Lim SH; Anantharaman V; Teo WS; Chan YH
    Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy.
    Summers MA; Moore JL; McAuley JW
    Ann Pharmacother; 2004 Oct; 38(10):1631-4. PubMed ID: 15328394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus.
    Bankstahl JP; Löscher W
    Epilepsy Res; 2008 Nov; 82(1):70-85. PubMed ID: 18760905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor and electrographic response of refractory experimental status epilepticus in rats and effect of calcium channel blockers.
    George B; Kulkarni SK; Mathur R
    Indian J Exp Biol; 2000 Feb; 38(2):105-12. PubMed ID: 11218825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil attenuates the malignant treatment course in recurrent status epilepticus.
    Schmitt FC; Dehnicke C; Merschhemke M; Meencke HJ
    Epilepsy Behav; 2010 Apr; 17(4):565-8. PubMed ID: 20189886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy.
    Iannetti P; Parisi P; Spalice A; Ruggieri M; Zara F
    Epilepsy Res; 2009 Jul; 85(1):89-95. PubMed ID: 19303743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of refractory focal status epilepticus by the P-glycoprotein inhibitor verapamil.
    Pirker S; Baumgartner C
    Eur J Neurol; 2011 Dec; 18(12):e151. PubMed ID: 22097953
    [No Abstract]   [Full Text] [Related]  

  • 9. Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data.
    Hsiao P; Sasongko L; Link JM; Mankoff DA; Muzi M; Collier AC; Unadkat JD
    J Pharmacol Exp Ther; 2006 May; 317(2):704-10. PubMed ID: 16415090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of novel AMPA antagonist, NS1209, on status epilepticus. An experimental study in rat.
    Pitkänen A; Mathiesen C; Rønn LC; Møller A; Nissinen J
    Epilepsy Res; 2007 Apr; 74(1):45-54. PubMed ID: 17289347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very-high-dose phenobarbital for childhood refractory status epilepticus.
    Lee WK; Liu KT; Young BW
    Pediatr Neurol; 2006 Jan; 34(1):63-5. PubMed ID: 16376283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil in treatment resistant depression: a role for the P-glycoprotein transporter?
    Clarke G; O'Mahony SM; Cryan JF; Dinan TG
    Hum Psychopharmacol; 2009 Apr; 24(3):217-23. PubMed ID: 19212940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of calcium channel blockers on the central action of clonidine.
    Czarnecka E; Tymczyszyn W
    Pol J Pharmacol; 1994; 46(3):125-31. PubMed ID: 8000443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of electrical status epilepticus during slow-wave sleep with high-dose corticosteroid.
    Okuyaz C; Aydin K; Gücüyener K; Serdaroğlu A
    Pediatr Neurol; 2005 Jan; 32(1):64-7. PubMed ID: 15607609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aborted and refractory status epilepticus in children: a comparative analysis.
    Lambrechtsen FA; Buchhalter JR
    Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased P-glycoprotein function and level after long-term exposure of four antiepileptic drugs to rat brain microvascular endothelial cells in vitro.
    Yang HW; Liu HY; Liu X; Zhang DM; Liu YC; Liu XD; Wang GJ; Xie L
    Neurosci Lett; 2008 Apr; 434(3):299-303. PubMed ID: 18313849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.
    Brandt C; Gastens AM; Sun Mz; Hausknecht M; Löscher W
    Neuropharmacology; 2006 Sep; 51(4):789-804. PubMed ID: 16806297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and treatment of refractory status epilepticus in the intensive care unit.
    Drislane FW; Lopez MR; Blum AS; Schomer DL
    J Clin Neurophysiol; 2008 Aug; 25(4):181-6. PubMed ID: 18677181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Add-on treatment with verapamil in pharmacoresistant canine epilepsy.
    Jambroszyk M; Tipold A; Potschka H
    Epilepsia; 2011 Feb; 52(2):284-91. PubMed ID: 21219313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam in nonconvulsive status epilepticus in childhood: a case report.
    Trabacca A; Profice P; Costanza MC; Gesualdi M; De Rinaldis M
    J Child Neurol; 2007 May; 22(5):639-41. PubMed ID: 17690075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.